Search Results

There are 28401 results for: content related to: Design Platforms of Nanocapsules for Human Therapeutics or Vaccines

  1. Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity

    Biotechnology and Bioengineering

    Volume 112, Issue 6, June 2015, Pages: 1102–1110, Jaina M. Patel, Vincent F. Vartabedian, Min-Chul Kim, Sara He, Sang-Moo Kang and Periasamy Selvaraj

    Version of Record online : 17 APR 2015, DOI: 10.1002/bit.25537

  2. You have free access to this content
    Polyomavirus EGFP-pseudocapsids: Analysis of model particles for introduction of proteins and peptides into mammalian cells

    FEBS Letters

    Volume 579, Issue 29, December 05, 2005, Pages: 6549–6558, E. Bouřa, D. Liebl, R. Špíšek, J. Frič, M. Marek, J. Štokrová, V. Holáň and J. Forstová

    Version of Record online : 10 NOV 2005, DOI: 10.1016/j.febslet.2005.10.062

  3. Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis

    Journal of Viral Hepatitis

    Volume 19, Issue 6, June 2012, Pages: 436–448, N. Kapur, D. Thakral, H. Durgapal and S. K. Panda

    Version of Record online : 2 DEC 2011, DOI: 10.1111/j.1365-2893.2011.01559.x

  4. You have free access to this content
    Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles

    The FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1198–1208, Yang Pan, Yuan Zhang, Tingting Jia, Kuo Zhang, Jinming Li and Lunan Wang

    Version of Record online : 23 FEB 2012, DOI: 10.1111/j.1742-4658.2012.08512.x

  5. Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 12, December 2011, Pages: 5156–5173, Lei Hu, Jared M. Trefethen, Yuhong Zeng, Luisa Yee, Satoshi Ohtake, David Lechuga-Ballesteros, Kelly L. Warfield, M. Javad Aman, Sergey Shulenin, Robert Unfer, Sven G. Enterlein, Vu Truong-Le, David B. Volkin, Sangeeta B. Joshi and C. Russell Middaugh

    Version of Record online : 19 AUG 2011, DOI: 10.1002/jps.22724

  6. Construction of target-specific virus-like particles for the delivery of algicidal compounds to harmful algae

    Environmental Microbiology

    Volume 17, Issue 4, April 2015, Pages: 1463–1474, Beom Sik Kang, Chi-Yong Eom, Wonduck Kim, Pyoung il Kim, Sun Yi Ju, Jaewon Ryu, Gui Hwan Han, Jeong-Il Oh, Hoon Cho, Seung Ho Baek, Gueeda Kim, Minju Kim, Jaekyung Hyun, EonSeon Jin and Si Wouk Kim

    Version of Record online : 17 DEC 2014, DOI: 10.1111/1462-2920.12650

  7. Quantifying Lipid Contents in Enveloped Virus Particles with Plasmonic Nanoparticles

    Small

    Volume 11, Issue 13, April 1, 2015, Pages: 1592–1602, Amin Feizpour, Xinwei Yu, Hisashi Akiyama, Caitlin M. Miller, Ethan Edmans, Suryaram Gummuluru and Björn M. Reinhard

    Version of Record online : 10 NOV 2014, DOI: 10.1002/smll.201402184

  8. Development of virus-like particles for diagnostic and prophylactic biomedical applications

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

    Volume 7, Issue 5, September/October 2015, Pages: 722–735, Benjamin Schwarz and Trevor Douglas

    Version of Record online : 13 FEB 2015, DOI: 10.1002/wnan.1336

  9. Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles

    Biotechnology Journal

    Volume 10, Issue 5, May 2015, Pages: 715–727, Christopher Ladd Effio and Jürgen Hubbuch

    Version of Record online : 16 APR 2015, DOI: 10.1002/biot.201400392

  10. You have free access to this content
    Highly efficient transport of carboxyfluorescein diacetate succinimidyl ester into COS7 cells using human papillomavirus-like particles

    FEBS Letters

    Volume 536, Issue 1-3, February 11, 2003, Pages: 120–124, Christian Bergsdorf, Carsten Beyer, Viktor Umansky, Margaret Werr and Martin Sapp

    Version of Record online : 22 JAN 2003, DOI: 10.1016/S0014-5793(03)00039-5

  11. You have free access to this content
    Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion

    European Journal of Immunology

    Volume 41, Issue 11, November 2011, Pages: 3240–3252, Virginie M. Renoux, Bettina Bisig, Inge Langers, Estelle Dortu, Béatrice Clémenceau, Marc Thiry, Christophe Deroanne, Alain Colige, Jacques Boniver, Philippe Delvenne and Nathalie Jacobs

    Version of Record online : 27 SEP 2011, DOI: 10.1002/eji.201141693

  12. Enterovirus71 virus-like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice

    Journal of Applied Microbiology

    Volume 119, Issue 4, October 2015, Pages: 1196–1205, D. Zhao, B. Sun, H. Jiang, S. Sun, F.T. Kong, Y. Ma, L. Jiang, L. Bai, X. Chen, P. Yang, C. Liu, Y. Xu, W. Su, W. Kong, F. Xu and C. Jiang

    Version of Record online : 20 SEP 2015, DOI: 10.1111/jam.12922

  13. Quantitative characterization of virus-like particles by asymmetrical flow field flow fractionation, electrospray differential mobility analysis, and transmission electron microscopy

    Biotechnology and Bioengineering

    Volume 102, Issue 3, 15 February 2009, Pages: 845–855, Leonard F. Pease III, Daniel I. Lipin, De-Hao Tsai, Michael R. Zachariah, Linda H.L. Lua, Michael J. Tarlov and Anton P.J. Middelberg

    Version of Record online : 18 AUG 2008, DOI: 10.1002/bit.22085

  14. Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: Basis for a virus-like particle ELISA

    Journal of Medical Virology

    Volume 75, Issue 1, January 2005, Pages: 114–121, Oliver Rommel, Joakim Dillner, Claudia Fligge, Christian Bergsdorf, Xiaohong Wang, Hans-Christoph Selinka and Martin Sapp

    Version of Record online : 12 NOV 2004, DOI: 10.1002/jmv.20245

  15. Virus-like particles as HIV-1 vaccines

    Reviews in Medical Virology

    Volume 15, Issue 2, March/April 2005, Pages: 75–88, Linh X. Doan, Min Li, Changyi Chen and Qizhi Yao

    Version of Record online : 14 OCT 2004, DOI: 10.1002/rmv.449

  16. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

    Volume 3, Issue 2, March/April 2011, Pages: 174–196, Emily M. Plummer and Marianne Manchester

    Version of Record online : 24 SEP 2010, DOI: 10.1002/wnan.119

  17. You have full text access to this Open Access content
    The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza

    Plant Biotechnology Journal

    Volume 8, Issue 5, June 2010, Pages: 607–619, Marc-André D’Aoust, Manon M.-J. Couture, Nathalie Charland, Sonia Trépanier, Nathalie Landry, Frédéric Ors and Louis-P. Vézina

    Version of Record online : 18 FEB 2010, DOI: 10.1111/j.1467-7652.2009.00496.x

  18. The incorporation of the A2 protein to produce novel Qβ virus-like particles using cell-free protein synthesis

    Biotechnology Progress

    Volume 28, Issue 2, March/April 2012, Pages: 549–555, Mark T. Smith, Chad T. Varner, Derek B. Bush and Bradley C. Bundy

    Version of Record online : 28 NOV 2011, DOI: 10.1002/btpr.744

  19. You have free access to this content
    Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications

    Protein Science

    Volume 18, Issue 7, July 2009, Pages: 1425–1438, Maxime J. J. Fleury, Antoine Touzé, Marie-Christine Maurel, Thierry Moreau and Pierre Coursaget

    Version of Record online : 20 MAY 2009, DOI: 10.1002/pro.156

  20. You have free access to this content
    Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system

    FEBS Letters

    Volume 576, Issue 1-2, October 08, 2004, Pages: 174–178, Eduardo Mortola and Polly Roy

    Version of Record online : 18 SEP 2004, DOI: 10.1016/j.febslet.2004.09.009